HEATR8 Inhibitors
HEATR8 Inhibitors, as conceptualized here, encompass a range of chemicals that can indirectly affect the function or expression of the HEATR8 protein. These compounds have been selected based on their ability to influence cellular pathways and processes that are potentially related to the activity of HEATR8. For instance, inhibitors of protein synthesis like Cycloheximide and translational pathways such as those affected by Rapamycin can lead to reduced expression of a broad spectrum of proteins, including potentially HEATR8. Compounds that disrupt protein trafficking (Brefeldin A) or protein degradation (MG132) can also affect the levels and functionality of HEATR8 within the cell by preventing its proper localization or by leading to its accumulation, respectively.
Further, the use of kinase inhibitors like Staurosporine, LY294002, and U0126, as well as the p38 MAP kinase inhibitor SB203580, suggests a strategy of modulating cellular signaling cascades that could alter the activity or expression of HEATR8. Hsp90 inhibitors like 17-AAG can disrupt the folding and stability of client proteins, thereby potentially affecting HEATR8 if it interacts with Hsp90. Okadaic Acid's inhibition of protein phosphatases and Thapsigargin's disruption of calcium homeostasis can lead to changes in the phosphorylation state or signaling events that may indirectly impact the function of HEATR8.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can influence protein synthesis and potentially affect proteins involved in similar pathways or processes as HEATR8. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, potentially reducing the overall levels of proteins, including HEATR8. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of protein molecules between the endoplasmic reticulum and Golgi apparatus, potentially affecting the processing and trafficking of HEATR8. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to the accumulation of polyubiquitinated proteins, possibly affecting the degradation pathway of HEATR8. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can affect various signaling pathways, potentially altering the cellular processes in which HEATR8 is involved. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can affect multiple signaling pathways, possibly influencing the function or expression of HEATR8. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that can affect signaling pathways, potentially altering the function or cellular localization of HEATR8. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, possibly affecting signaling pathways that could influence HEATR8 activity or stability. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Hsp90 inhibitor that can disrupt client protein folding and stability, possibly affecting the proper function of HEATR8 if it is an Hsp90 client protein. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, potentially altering phosphorylation states of proteins and affecting signaling pathways involving HEATR8. | ||||||